Exogenous Protein Delivery of Ionic Liquid-Mediated HMGB1 Coating on Titanium Implants
Langmuir · 2023
DOI: 10.1021/acs.langmuir.2c02688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Langmuir, 2023. Verfasst von Alexandra Arteaga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, The University of Texas at Dallas, Richardson, Texas75080, United States. Hauptthemen laut MEDLINE: Ionic Liquids, HMGB1 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, University of Texas at Dallas.
Abstract (Originalsprache)
Strategies for modifying titanium (Ti) implant surfaces are becoming increasingly popular to enhance osseointegration during acute and inflammatory healing stages. In this study, two dicationic imidazolium-based ionic liquids (IonLs) containing phenylalanine and methionine anions (IonL-Phe(1,10-bis(3-methylimidazolium-1-yl)decane diphenylalanine) and IonL-Met(1,10-bis(3-methylimidazolium-1-yl)decane dimethionine)) were investigated to stably deliver exogenous proteins on Ti to promote osseointegration. The protein selected for this study is High-Mobility Group Box 1 (HMGB1), which recruits inflammatory and mesenchymal stem cells to the implantation site, contributing to healing. To explore IonL-Ti interactions and HMGB1 stability on the IonL-coated surface, experimental characterization techniques including X-ray photoelectron spectroscopy, scanning electron microscopy, dynamic scanning calorimetry (DSC), and liquid chromatography mass spectrometry (LC-MS) were used along with molecular dynamics (MD) computer simulations to provide a detailed molecular level description. Results show well-structured IonL molecules on the Ti surface that impact protein crystallization and coating morphology. IonL cations and anions were found to bind strongly to oppositely charged residues of the protein. LC-MS/MS reveals that HMGB1 B-box lysine residues bind strongly to the IonLs. Stronger interactions of HMGB1 with Ion-Phe in contrast to IonL-Met results in greater retention capacity of HMGB1 in the IonL-Phe coating. Overall, this study provides evidence that the selected IonLs strongly interact with HMGB1, which can be a potential surface treatment for bone-implantable Ti devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, The University of Texas at Dallas, Richardson, Texas75080, United States.
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, Texas75080, United States.
- School of Dentistry, University of Texas Health San Antonio, San Antonio, Texas78229, United States.
- School of Medicine, University of Texas Rio Grande Valley, Edinburg, Texas78539, United States.
ORCID-Profile: Dineli T S Ranathunga, Steven O Nielsen, Danieli C Rodrigues
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- University of Texas at Dallas
Zitieren
APA
Arteaga, A., Ranathunga, D. T. S., Qu, J., Biguetti, C. C., Nielsen, S. O., & C Rodrigues, D. (2023). Exogenous Protein Delivery of Ionic Liquid-Mediated HMGB1 Coating on Titanium Implants. Langmuir. https://doi.org/10.1021/acs.langmuir.2c02688
Vancouver
Arteaga A, Ranathunga DTS, Qu J, Biguetti CC, Nielsen SO, C Rodrigues D. Exogenous Protein Delivery of Ionic Liquid-Mediated HMGB1 Coating on Titanium Implants. Langmuir. 2023. doi:10.1021/acs.langmuir.2c02688
BibTeX
@article{Arteaga2023,
author = {Arteaga, Alexandra and Ranathunga, Dineli T S and Qu, Jiayi and Biguetti, Claudia C and Nielsen, Steven O and C Rodrigues, Danieli},
title = {Exogenous Protein Delivery of Ionic Liquid-Mediated HMGB1 Coating on Titanium Implants},
journal = {Langmuir},
year = {2023},
doi = {10.1021/acs.langmuir.2c02688}
}
EUVIMED